Informations générales (source: ClinicalTrials.gov)
A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
Observational
Perouse Medical (Voir sur ClinicalTrials)
mars 2022
octobre 2022
03 août 2024
The purpose of this study is to evaluate performance and safety of POLYSITE® and SEESITE®
implantable ports allowing repeated and prolonged access to the venous system for the
administration of chemotherapy, antibiotics, antiviral drugs, parenteral nutrition, and
for blood transfusion or blood derivatives transfusion.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FOCH | Alexandre Valée, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHR d'Orléans - 45100 - Orléans - France | Adel Abou Mrad, MD | Contact (sur clinicalTrials) | |||
| IGR - 94805 - Villejuif - France | Frédéric Gomas, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Adult and paediatric population
- Patient who received the implantation of any POLYSITE® or SEESITE® implantable port
referenced in the Annex 1 of the current protocol between 1-JAN-2018 and 31-DEC-2020
- Adult and paediatric population
- Patient who received the implantation of any POLYSITE® or SEESITE® implantable port
referenced in the Annex 1 of the current protocol between 1-JAN-2018 and 31-DEC-2020
- Patient who refused the data collection according to GDPR regulation applicable in
France
- Patient who received the implantation of another device than those presented in
Annex 1 of the current protocol.